Skip to Content

Qiagen NV

QGEN: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$52.00QlhsKztjhmjx

Qiagen's Operating Results Stabilizing After the Pandemic

Business Strategy and Outlook

Qiagen aims to help scientists and caregivers use biological samples to identify and solve problems related to DNA, RNA, and proteins, which should remain in demand even as the pandemic transitions into an endemic situation, albeit probably at a moderately lower rate. Qiagen's roots are in products that help scientists prepare biological samples for various experiments, and sample preparation products still account for about 35% of sales. Qiagen remains a key leader in this niche, and we expect Qiagen to continue to invest to maintain or improve in that business in the long run.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of QGEN so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center